{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/5e8308ce6b0fef1a38c4a215/66140a0d0201920016281518?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"How might the MORPHO trial of gilteritinib impact clinical practice?","description":"<p>The AML Hub spoke to Charles Craddock, Queen Elizabeth Hospital Birmingham, Birmingham, UK at ASH 2023. We asked, How might the MORPHO trial of gilteritinib impact clinical practice?</p>","author_name":"Scientific Education Support"}